Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2026 Financial Results

Click here to view

Presentation

Selective Repression of C9ORF72 Repeat Expansion-Containing Sense and Antisense Transcripts for the Treatment of ALS

Download PDF